Erdafitinib exerts its antitumor effect by selectively inhibiting FGFR1‑4, blocking downstream signaling to suppress tumor cell proliferation and survival.
Authentic
Guarantee
Fast Delivery
Privacy Erdafitinib, an FGFR inhibitor, may cause various adverse reactions when used to treat urothelial carcinoma with FGFR gene abnormalities.I. Common Sid···【More】
Update: 07 Apr,2026Source: BigbearViews: 92
Erdafitinib, an FGFR inhibitor, is used to treat urothelial carcinoma with specific gene abnormalities.I. Erdafitinib Dosage and Administration1. Stan···【More】
Update: 07 Apr,2026Source: BigbearViews: 89
Erdafitinib is an FGFR-targeting kinase inhibitor used to treat urothelial carcinoma with specific gene abnormalities.I. Erdafitinib Indications1. Uro···【More】
Update: 07 Apr,2026Source: BigbearViews: 93
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



